Tourmaline Bio shares are trading higher after a Friday filing showed Pfizer reported a 6.29% stake in the company.

Delist

Tourmaline Bio, Inc. - Common Stock

TRML

0.00

Tourmaline Bio shares are trading higher after a Friday filing showed Pfizer reported a 6.29% stake in the company.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Weekly Watch | Dividend Alert for JARIR (4190), FITAIHI GROUP(4180), FITNESS TIME(1830) and More; Spotlight on Saudi: Industrial Production & Inflation Data

Pre-Bell Movers | MSGM Improves Considerably by 92.7%; Here Are 20 Stocks Moving Premarket

InflaRx To Present Data From Phase 2a Clinical Study Of Oral C5ar Inhibitor INF904 In Participants With Hidradenitis Suppurativa And Chronic Spontaneous Urticaria On Nov. 10

Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy

Greenidge Generation Reaches Agreement With New York For 5-Year Air Permit Renewal, Cutting Emissions 44% By 2030, Ending All Litigation

MiNK Therapeutics Files For Mixed Shelf Offering Up To $150M

Trilogy Metals To Sell Shares Up To $200M

CIF/FOB Gulf Grain-Soybean barge bids steady-firm, corn flat-weaker